Kinetics of aggrecanase- and metalloproteinase-induced neoepitopes in various stages of cartilage destruction in murine arthritis
Open Access
- 1 June 1999
- journal article
- basic science
- Published by Wiley in Arthritis & Rheumatism
- Vol. 42 (6) , 1128-1139
- https://doi.org/10.1002/1529-0131(199906)42:6<1128::aid-anr9>3.0.co;2-2
Abstract
Objective Two major cleavage sites, one mediated by metalloproteinases (MMPs) and the other by an as‐yet unidentified enzyme termed aggrecanase, have been observed in aggrecan. To learn more about the relative contribution of these enzymes during cartilage degradation, this study assessed the occurrence of both specific neoepitopes in cartilage during murine arthritis and examined the correlation between neoepitope formation and different aspects of cartilage damage. Methods Reversible cartilage damage was induced in mice in the zymosan‐induced arthritis (ZIA) model, partly irreversible cartilage damage in the antigen‐induced arthritis (AIA) model, and irreversible, destructive cartilage damage in the collagen‐induced arthritis (CIA) model. Immunolocalization techniques were used to detect the specific C‐terminal neoepitopes VDIPEN (MMPs) and NITEGE (aggrecanase). Results In normal cartilage from young adult mice, no VDIPEN epitopes were detected, but a limited amount of NITEGE epitopes were already present. During the early phase of proteoglycan (PG) depletion, NITEGE expression was raised substantially in all arthritis models. VDIPEN epitopes were not detected in this early phase of cartilage destruction. When PG depletion progressed toward advanced cartilage damage, VDIPEN epitopes were induced. During ZIA, minimal induction of VDIPEN was observed, whereas in AIA, strong, but partly reversible, VDIPEN staining was evident, and in CIA, an extensive presence and persistence of the MMP‐induced neoepitope was seen. When VDIPEN epitopes were intensely present, NITEGE epitopes were greatly reduced at that site in the cartilage. Conclusion Presence of VDIPEN epitopes in cartilage correlated with severe cartilage damage, but these epitopes were not detected during early PG degradation. This suggests a limited role for VDIPEN‐inducing MMPs in early PG degradation during murine arthritis. In contrast, aggrecanase epitopes were induced before the appearance of VDIPEN epitopes, but they disappeared with progression of cartilage damage.Keywords
This publication has 32 references indexed in Scilit:
- Aggrecan degradation in human cartilage. Evidence for both matrix metalloproteinase and aggrecanase activity in normal, osteoarthritic, and rheumatoid joints.Journal of Clinical Investigation, 1997
- Degradation of type II collagen, but not proteoglycan, correlates with matrix metalloproteinase activity in cartilage explant culturesArthritis & Rheumatism, 1997
- Aggrecan is degraded by matrix metalloproteinases in human arthritis. Evidence that matrix metalloproteinase and aggrecanase activities can be independent.Journal of Clinical Investigation, 1996
- Anticytokine treatment of established type II collagen–induced arthritis in DBA/1 mice: A comparative study using anti‐TNFα, anti–IL‐1α/β, and IL‐1RaArthritis & Rheumatism, 1996
- Role of interleukin‐1, tumor necrosis factor α, and interleukin‐6 in cartilage proteoglycan metabolism and destruction effect of in situ blocking in murine antigen‐ and zymosan‐induced arthritisArthritis & Rheumatism, 1995
- Cell-mediated Catabolism of AggrecanPublished by Elsevier ,1995
- The structure of aggrecan fragments in human synovial fluid. Evidence for the involvement in osteoarthritis of a novel proteinase which cleaves the Glu 373-Ala 374 bond of the interglobular domain.Journal of Clinical Investigation, 1992
- Autoimmunity to type II collagen an experimental model of arthritis.The Journal of Experimental Medicine, 1977
- Antigen‐induced arthritis in miceArthritis & Rheumatism, 1977
- PERIODATE-LYSINE-PARAFORMALDEHYDE FIXATIVE A NEW FIXATIVE FOR IMMUNOELECTRON MICROSCOPYJournal of Histochemistry & Cytochemistry, 1974